adenosine has been researched along with Central Nervous System Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Deb, PK | 1 |
| Gao, X; Shi, JB; Wang, DY; Xia, Q | 1 |
| Chellappan, DK; Choudhury, H; Gorain, B; Pandey, M; Sengupta, P | 1 |
| Chen, J; Chen, NH; Chu, SF; Hu, YM; Li, X; Liu, YJ; Peng, Y; Zhou, X | 1 |
| Agnati, LF; Borroto-Escuela, DO; Ciruela, F; Fernández-Dueñas, V; Fuxe, K; Guescini, M; Marcellino, D; Rivera, A; Tanganelli, S | 1 |
| Foster, AC; Miller, LP; Wiesner, JB | 1 |
| Bernini, JC; Chappell, WB; Fort, DW; Griener, JC; Kamen, BA; Kane, BJ | 1 |
| Chrastina, P; Hansíková, H; Houstek, J; Kmoch, S; Krijt, J; Stratilová, L; Wenchich, L; Zeman, J | 1 |
| Hankiewicz, J; Lesniak, M | 1 |
5 review(s) available for adenosine and Central Nervous System Disease
| Article | Year |
|---|---|
The effects of m
Topics: Adenosine; Axons; Cell Differentiation; Central Nervous System; Central Nervous System Diseases; Gene Expression Regulation; Humans; Nerve Regeneration | 2020 |
Adenosine Receptors in Modulation of Central Nervous System Disorders.
Topics: Adenosine; Central Nervous System; Central Nervous System Diseases; Humans; Neurodegenerative Diseases; Receptors, Purinergic P1; Signal Transduction | 2019 |
Research progress on adenosine in central nervous system diseases.
Topics: Adenosine; Animals; Biomedical Research; Central Nervous System Diseases; Humans; Neuroprotective Agents; Purinergic P1 Receptor Agonists; Receptor, Adenosine A1; Receptor, Adenosine A2A | 2019 |
Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders.
Topics: Adenosine; Animals; Central Nervous System Diseases; Dopamine; Drug Interactions; Humans; Models, Biological; Models, Molecular; Receptors, Dopamine; Receptors, Purinergic P1; Signal Transduction | 2010 |
Regulation of endogenous adenosine levels in the CNS: potential for therapy in stroke, epilepsy and pain.
Topics: Adenosine; Animals; Central Nervous System; Central Nervous System Diseases; Cerebrovascular Disorders; Epilepsy; Homeostasis; Humans; Pain; Receptors, Purinergic P1 | 1994 |
1 trial(s) available for adenosine and Central Nervous System Disease
| Article | Year |
|---|---|
Aminophylline for methotrexate-induced neurotoxicity.
Topics: Adenosine; Adolescent; Aminophylline; Central Nervous System Diseases; Child; Child, Preschool; Female; Humans; Infusions, Parenteral; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1995 |
3 other study(ies) available for adenosine and Central Nervous System Disease
| Article | Year |
|---|---|
Therapeutic Potentials of Adenosine Receptors: The State of The Art.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Agonists; Arthritis, Rheumatoid; Central Nervous System Diseases; Humans; Neoplasms; Receptor, Adenosine A1; Receptor, Adenosine A2A; Signal Transduction | 2019 |
Abnormalities in succinylpurines in fumarase deficiency: possible role in pathogenesis of CNS impairment.
Topics: Adenosine; Aminoimidazole Carboxamide; Central Nervous System Diseases; Female; Fumarate Hydratase; Fumarates; Humans; Infant; Purines; Ribonucleosides | 2000 |
Adenosine deaminase in cerebrospinal fluid.
Topics: Adenosine; Adolescent; Adult; Aged; Aminohydrolases; Brain; Brain Neoplasms; Central Nervous System Diseases; Cerebellum; Cerebrospinal Fluid Proteins; Cerebrovascular Disorders; Child; Chlorides; Epilepsy; Female; Glioma; Glucose; Humans; Male; Meningioma; Meningitis; Middle Aged | 1972 |